enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asma - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - enfermedad pulmonar, obstructiva crónica - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - asma - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
libromide 325 mg comprimidos para perros
dechra regulatory b.v. - potasio bromuro - comprimido - potasio bromuro 325 - bromuros - perros
vetbromide 600 mg comprimidos para perros
domes pharma - potasio bromuro - comprimido - potasio bromuro 600 - potasio bromuro - perros
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - enfermedad pulmonar, obstructiva crónica - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
ultibro breezhaler 110/50mcg polvo para inhalacion en capsula dura
novartis biosciences peru s.a. - maleato de indacaterol; bromuro de glicopirronio; - polvo para inhalacion en capsula dura - por capsula - indacaterol
trimbow
chiesi farmaceutici s.p.a. - beclometasona dipropionato, formoterol fumarato dihidrato, bromuro de glicopirronio - enfermedad pulmonar, obstructiva crónica - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
bretaris genuair
covis pharma europe b.v. - aclidinium bromide - enfermedad pulmonar, obstructiva crónica - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - bretaris genuair está indicado como un tratamiento broncodilatador de mantenimiento para aliviar los síntomas en pacientes adultos con enfermedad pulmonar obstructiva crónica (epoc).
nulibry
tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - otros tracto alimentario y metabolismo de los productos, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.